The breast cancer series aims to highlight these key issues and foster focused discussions amongst UICC members and renowned experts on key actions needed to reduce the global breast cancer burden.
Despite advances and progress seen in breast cancer in recent years, current data highlights that breast cancer incidence and mortality remain the highest for cancer in women, with over 2.2 million new cases and 684,996 deaths in 2020 (GLOBOCAN 2020).This trend is expected to accelerate in the next 20 years, with a disproportionate number of cases and deaths expected to occur in low-resource settings.
To tackle the growing breast cancer burden, it is critical that improvements are made in
The Programme is supported by Pfizer (Founding Partner), Daiichi Sankyo, Revolution Watch, the US National Cancer Institute Center for Global Health, Roche, in collaboration with the Breast Health Global Initiative, and WHO's Global Breast Cancer Initiative.
UICC's Virtual Dialogues provide members, and the cancer community, with regular opportunities to connect, exchange knowledge, access expert insights, and share solutions from the comfort of one's office or home.
UICC and the Canadian Partnership Against Cancer are organising a series of discussions looking at alcohol and cancer to help better inform and connect the cancer community.
UICC aims to engage all key stakeholders in the tobacco control and cancer communities in discussing key actions to ensure global committments on tobacco control translate into national policy actions ultimately leading to a reduction in the burden of tobacco-related cancer and other diseases.
In this series UICC and Jhpiego will bring global health leaders, advocates and policymakers together to discuss the challenges and solutions to creating an enabling environment which will accelerate towards the 90:70:90 targets by 2030.
UICC invited the cancer community to reflect on some of the changes set in motion by COVID-19, and discuss the implications for cancer prevention and control.
Share this page